NCT05253053 To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05243550 A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05235607 Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors Status UNKNOWN Phase PHASE1
NCT05219734 MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05204186 Impact of COMORBIDities After Radical Cystectomy Using a Predictive Method With Artificial Intelligence Status UNKNOWN Phase N/A
NCT05204108 Preoperative Detection of Muscle Invasion in Bladder Cancer with Contrast-enhanced Ultrasonography Status RECRUITING Phase N/A
NCT05200988 Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05195515 The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life Status ENROLLING_BY_INVITATION Phase N/A
NCT05180851 Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study Status UNKNOWN Phase EARLY_PHASE1
NCT05179824 Tempus Priority Study: A Pan-tumor Observational Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05167916 Can Four Weeks-check Cystoscopy and Urine Cytology After Primary Complete Resection of T1 Bladder Cancer Replace Repeat Biopsy? Status UNKNOWN Phase NA
NCT05153694 Infectious Complications After Cystectomy: A Prospective Observational Study Status RECRUITING Phase N/A
NCT05151341 Study of Combined VisioCyt Test and FGFR3 Mutations on a Urinary Sample to Diagnose Bladder Tumors Status COMPLETED Phase NA
NCT05148728 Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors Status UNKNOWN Phase NA